MIG Capital

Martlet Capital has invested in more than 65 start-ups, since its launch in 2011. In 2021, Martlet successfully raised additional capital to scale its investment activity. We provide patient capital for early-stage B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge. Our team is comprised of experienced investors and entrepreneurs. In addition to capital, we can offer support, experience and a network of contacts. We have achieved several exits from our portfolio, from trade sales to global technology companies and IPO’s.

We invest in opportunities backed by deep science. Xora is an early-stage investment platform of Temasek. We typically invest as a lead or co-lead investor in the Seed and Series A rounds, and later rounds (via our parent company). While we are not limited by geography, we prioritize opportunities that possess a strong linkage with the Singapore science & technology ecosystem. Leveraging the Temasek global network of investors and operating companies, we are active partners to ambitious founders building the next generation of impactful, world-changing companies. Our Team Our team possesses strong technical domain expertise in both physical and life sciences, and the intersection thereof, and are steeped in the nuances of early-stage deep science investing and venture building. We are global citizens with business experience in major markets. Our principles guide our engagement process and our investment decisions.We start with the people on the journey and a shared vision of the future. ​ We look for dogged persistence, unbounded creativity, acute self-awareness, a sense of urgency, and a passion for impact. We embrace both the technical and people complexity of science-based opportunities. ​ We welcome early and frequent contact and appreciate the opportunity to inform an emerging narrative. ​ We prefer brainstorming to pitches, and relationships to transactions. ​ We commit more than capital; we pledge our mindshare and our network.

Natural inclination towards Deeptech, Health and Behaviour Changes in Consumers' habits. We offer our investments direct and rapid access to decision-makers in the sectors they aim at transforming. Try us, also happy to coinvest.

We bring capital, deep domain expertise, operating experience with high-growth companies, and a far-reaching network to support our entrepreneur partners. Vanedge Capital is an early-stage venture capital fund based in Vancouver and Silicon Valley. As operators, we’ve built and led world-class companies. As investors, we apply our experience and our network to help exceptional entrepreneurs scale their businesses and attract follow-on capital from large institutional investors. We have developed a repeatable investment process that has been refined over more than a decade to create superior returns for our investors. Our investment strategy:Focus on technology themes - Our team’s deep technology background allows us to identify technology trends early, find diamonds in the rough, and attract the best founders as our partners. Mitigate execution risk - Our team’s operating experience and success with rapidly growing, deep technology companies makes us the respected board members that CEOs and other investors seek to help them create momentum, grow fast, and dominate new markets. Attract follow-on capital - Our portfolio companies benefit from a network of top-tier co-investors that we have built over 20 years. Our experience is that institutional capital worldwide is attracted to our de-risked, high-growth investment opportunities in foundational technology companies. Vanedge has $390 million under management.

We are in the age of discovery, seizing a unique moment in time. Every generation experiences a breakthrough that alters the world. Technology has transformed virtually every aspect of our lives, and now it’s healthcare’s turn. aMoon is here to accelerate this transformation. We partner with exceptional entrepreneurs who harness groundbreaking science and technology to transform healthcare. Through aMoon Velocity and aMoon Growth, we invest in early and late-stage companies pursuing disruptive, cutting-edge solutions for high unmet medical needs. We build bridges between our portfolio companies and global tech, finance and medical research hubs to enable entrepreneurs to turn their vision into reality.

Air Street Capital is a venture capital firm investing in AI-first technology and life science companies. We invest as early as possible and enjoy iterating through product, market and technology strategy from day 1. Our common goal is to create enduring companies that make a lasting impact on their markets.